APRE Aprea Therapeutics, Inc.
Healthcare · Market cap: $5.2M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $62.3K |
| 2022-Q2 | $59.5K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $37.0K | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $122.0K | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $165.9K | $29.6K |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $10.1K | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $31.0K | $0 |
| 2026-Q1 | $30.1K | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$455.5K22 buy days
Sold$200.8K3 sell days
Net insider flow+$254.7Knet buying · 5 years
Latest trade2026-01-30Gilad Oren
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-01-30 | Buy | Gilad Oren | CEO | 28,100 | $0.89 | $25.0K | 1 |
| 2026-01-30 | Buy | Hamill John P. | CFO | 5,700 | $0.89 | $5.1K | 1 |
| 2025-12-10 | Buy | Duey Marc | Director | 21,459 | $1.17 | $25.1K | 1 |
| 2025-12-10 | Buy | Hamill John P. | CFO | 5,000 | $1.17 | $5.8K | 1 |
| 2025-04-03 | Buy | Gilad Oren | CEO | 5,500 | $1.84 | $10.1K | 2 |
| 2024-10-23 | Buy | Gilad Oren | CEO | 500 | $3.92 | $2.0K | 1 |
| 2024-10-18 | Sell | Duey Marc | Director | 6,462 | $4.58 | $29.6K | 1 |
| 2024-10-16 | Buy | Duey Marc | Director | 30,000 | $4.39 | $131.7K | 1 |
| 2024-10-15 | Buy | Gilad Oren | CEO | 250 | $2.90 | $725 | 1 |
| 2024-10-14 | Buy | Gilad Oren | CEO | 1,000 | $2.59 | $2.6K | 1 |
| 2024-10-14 | Buy | Duey Marc | Director | 190 | $2.58 | $490 | 1 |
| 2024-10-11 | Buy | Seizinger Bernd R. | Director | 10,000 | $2.68 | $26.8K | 1 |
| 2024-10-11 | Buy | Hamill John P. | CFO | 50 | $2.46 | $123 | 1 |
| 2024-10-10 | Buy | Hamill John P. | CFO | 450 | $2.61 | $1.2K | 1 |
| 2024-10-10 | Buy | Gilad Oren | CEO | 150 | $2.54 | $381 | 1 |
| 2024-03-13 | Buy | Seizinger Bernd R. | Director | 6,860 | $7.29 | $50.0K | 1 |
| 2024-03-13 | Buy | HENNEMAN JOHN B III | Director | 6,860 | $7.29 | $50.0K | 1 |
| 2024-03-13 | Buy | Gilad Oren | CEO | 2,000 | $7.29 | $14.6K | 1 |
| 2024-03-13 | Buy | Hamill John P. | CFO | 1,010 | $7.29 | $7.4K | 1 |
| 2023-06-07 | Buy | Seizinger Bernd R. | Director | 6,029 | $3.68 | $22.2K | 1 |
| 2023-06-06 | Buy | Seizinger Bernd R. | Director | 4,068 | $3.63 | $14.8K | 1 |
| 2022-05-18 | Buy | Seizinger Bernd R. | Director | 50,000 | $0.71 | $35.5K | 1 |
| 2022-05-18 | Buy | SCHADE CHRISTIAN S | CEO | 37,500 | $0.64 | $24.0K | 1 |
| 2022-02-28 | Sell | Attar Eyal C. | Other C-suite | 36,000 | $1.73 | $62.3K | 1 |
| 2021-12-01 | Sell | Korbel Gregory Alan | Other C-suite | 27,500 | $3.96 | $108.9K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Duey Marc | Director | $157.3K | $29.6K | 2025-12-10 |
| Seizinger Bernd R. | Director | $149.3K | $0 | 2024-10-11 |
| Korbel Gregory Alan | Other C-suite | $0 | $108.9K | 2021-12-01 |
| Attar Eyal C. | Other C-suite | $0 | $62.3K | 2022-02-28 |
| Gilad Oren | CEO | $55.4K | $0 | 2026-01-30 |
| HENNEMAN JOHN B III | Director | $50.0K | $0 | 2024-03-13 |
| SCHADE CHRISTIAN S | CEO | $24.0K | $0 | 2022-05-18 |
| Hamill John P. | CFO | $19.6K | $0 | 2026-01-30 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-10-10 → 2024-10-23 | 4 | $165.9K | 52 | +21.3% (+26.9% raw) | +42.9% (+44.0% raw) | -26.5% (-42.3% raw) | closed |
| 2024-03-13 | 4 | $122.0K | 39 | +7.5% (+4.7% raw) | -20.5% (-21.2% raw) | -53.5% (-44.8% raw) | closed |
| 2019-10-07 | 12 | $29.3M | 66 | +18.2% (+23.8% raw) | +100.5% (+112.6% raw) | +68.4% (+63.6% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.